Susan Thomas of Georgia Tech Research Corporation will receive $450,000 in breast cancer research funding.
OCI has developed a method to detect ovarian cancer that is highly accurate in patients with Stage 1 disease.
Researchers at the Georgia Institute of Technology are using unique identifying number principles to track cells being sorted on microfluidic chips.
A new study has produced a set of biomarkers that may enable development of an accurate ovarian cancer screening test.
New research by Georgia Tech scientists underscores importance of gene regulation